Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 10 of 10 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Eyedesis Biosciences LLC | Activity: Research and Development | Company Description Eyedesis Biosciences is developing a small-molecule macrophage inhibitor for the treatment of neovascular age related macular degeneration. | Location Chapel Hill |
| |
Company Gilero (Pittsboro) | Activity: Production and Manufacturing | Company Description Gilero provides design, development and contract manufacturing services in the medical device and drug delivery markets. The Pittsboro site is a manufacturing facility specializing in device assembly, kitting and packaging services. | Location Pittsboro |
| |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill |
| |
Company HOMS LLC | Activity: Production and Manufacturing | Company Description HOMS develops, manufactures and markets natural products for pest management. | Location Pittsboro |
| |
Company Irex Pharma LLC | Activity: Research and Development | Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. | Location Chapel Hill |
| |
Company Juno Metabolomics LLC | Activity: Production and Manufacturing | Company Description Juno Metabolomics is developing next-generation metabolomics for precision medicine. | Location Chapel Hill |
| |
Company New Hope Biodiagnostics LLC | Activity: Research and Development | Company Description New Hope Biodiagnostics is developing biodiagnostics for cancer. | Location Chapel Hill |
| |
Company NuRevelation LLC | Activity: Research and Development | Company Description NuRevelation develops drug delivery methods for pharmaceuticals, nutraceuticals and cannabinoids. | Location Durham |
| |
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill |
| |
Company Xyzagen Inc. | Activity: Contract Research and Testing | Company Description Xyzagen is a non-GLP LC-MS/MS bioanalytical lab with rodent in vivo pharmacokinetics and pharmacology research vivarium. Xyzagen also offers clinical pharmacology/pharmokinetics and GLP toxicokinetic support. | Location Pittsboro |